A detailed history of Aspiriant, LLC transactions in Berkshire Hathaway Inc Class B stock. As of the latest transaction made, Aspiriant, LLC holds 1,000 shares of BRK-B stock, worth $454,900. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,000
Previous 66,531 98.5%
Holding current value
$454,900
Previous $27.1 Million 98.3%
% of portfolio
0.02%
Previous 1.11%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

SELL
$405.19 - $478.57 $669,779 - $791,076
-1,653 Reduced 2.48%
64,878 $29.9 Million
Q2 2024

Jul 15, 2024

SELL
$396.73 - $420.24 $1.09 Million - $1.16 Million
-2,760 Reduced 3.98%
66,531 $27.1 Million
Q1 2024

Apr 15, 2024

SELL
$359.29 - $420.52 $44,911 - $52,565
-125 Reduced 0.18%
69,291 $29.1 Million
Q4 2023

Jan 26, 2024

BUY
$331.71 - $362.68 $222,245 - $242,995
670 Added 0.97%
69,416 $24.8 Million
Q3 2023

Oct 17, 2023

SELL
$340.9 - $370.48 $58,634 - $63,722
-172 Reduced 0.25%
68,746 $24.1 Million
Q2 2023

Jul 19, 2023

SELL
$309.07 - $341.0 $254,673 - $280,984
-824 Reduced 1.18%
68,918 $23.5 Million
Q1 2023

Apr 27, 2023

BUY
$293.51 - $320.37 $447,896 - $488,884
1,526 Added 2.24%
69,742 $21.5 Million
Q4 2022

Jan 23, 2023

BUY
$264.0 - $318.6 $102,960 - $124,254
390 Added 0.58%
68,216 $0
Q3 2022

Oct 28, 2022

SELL
$264.32 - $306.65 $180,794 - $209,748
-684 Reduced 1.0%
67,826 $18.1 Million
Q2 2022

Jul 25, 2022

BUY
$267.52 - $353.1 $73,835 - $97,455
276 Added 0.4%
68,510 $18.7 Million
Q1 2022

May 06, 2022

SELL
$300.79 - $359.57 $166,336 - $198,842
-553 Reduced 0.8%
68,234 $24.1 Million
Q4 2021

Feb 14, 2022

BUY
$273.64 - $300.17 $578,474 - $634,559
2,114 Added 3.17%
68,787 $20.6 Million
Q3 2021

Oct 27, 2021

SELL
$272.66 - $291.28 $253,301 - $270,599
-929 Reduced 1.37%
66,673 $18.2 Million
Q2 2021

Aug 13, 2021

SELL
$258.2 - $292.52 $305,450 - $346,051
-1,183 Reduced 1.72%
67,602 $18.8 Million
Q1 2021

May 11, 2021

SELL
$227.36 - $263.99 $448,808 - $521,116
-1,974 Reduced 2.79%
68,785 $17.6 Million
Q4 2020

Feb 01, 2021

SELL
$200.7 - $233.92 $904,153 - $1.05 Million
-4,505 Reduced 5.99%
70,759 $16.4 Million
Q3 2020

Oct 29, 2020

BUY
$177.99 - $221.68 $380,542 - $473,951
2,138 Added 2.92%
75,264 $16 Million
Q2 2020

Aug 06, 2020

SELL
$169.25 - $201.56 $350,855 - $417,833
-2,073 Reduced 2.76%
73,126 $13.1 Million
Q1 2020

May 05, 2020

SELL
$162.13 - $230.2 $1.33 Million - $1.89 Million
-8,194 Reduced 9.83%
75,199 $13.7 Million
Q4 2019

Jan 27, 2020

SELL
$203.1 - $227.05 $289,214 - $323,319
-1,424 Reduced 1.68%
83,393 $18.9 Million
Q3 2019

Nov 04, 2019

SELL
$195.81 - $215.25 $290,190 - $319,000
-1,482 Reduced 1.72%
84,817 $17.6 Million
Q2 2019

Aug 06, 2019

SELL
$197.42 - $218.6 $194,853 - $215,758
-987 Reduced 1.13%
86,299 $18.4 Million
Q1 2019

May 03, 2019

SELL
$191.66 - $209.19 $1.58 Million - $1.73 Million
-8,256 Reduced 8.64%
87,286 $17.5 Million
Q4 2018

Feb 04, 2019

SELL
$187.76 - $223.76 $340,408 - $405,676
-1,813 Reduced 1.86%
95,542 $19.5 Million
Q3 2018

Oct 26, 2018

SELL
$186.02 - $221.68 $694,970 - $828,196
-3,736 Reduced 3.7%
97,355 $20.8 Million
Q2 2018

Aug 07, 2018

SELL
$184.91 - $201.2 $605,765 - $659,131
-3,276 Reduced 3.14%
101,091 $18.9 Million
Q1 2018

May 04, 2018

BUY
$191.42 - $217.25 $7.65 Million - $8.68 Million
39,956 Added 62.03%
104,367 $20.8 Million
Q4 2017

Jan 31, 2018

SELL
$181.06 - $199.56 $9.08 Million - $10 Million
-50,170 Reduced 43.79%
64,411 $12.8 Million
Q3 2017

Nov 13, 2017

BUY
$173.99 - $183.82 $19.9 Million - $21.1 Million
114,581
114,581 $21 Million

Others Institutions Holding BRK-B

About BERKSHIRE HATHAWAY INC - Class B


  • Ticker BRK-B
  • Exchange NYSE
  • Sector Financial Services
  • Industry Insurance—Diversified
  • Shares Outstandng 1,301,129,984
  • Market Cap $592B
More about BRK-B
Track This Portfolio

Track Aspiriant, LLC Portfolio

Follow Aspiriant, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aspiriant, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aspiriant, LLC with notifications on news.